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There is a need for easy-to-use molecular assays for diagnosis of invasive
meningococcal disease. Here, we report the rapid identiﬁcation of Neisseria menin-
gitidis in a cerebrospinal ﬂuid sample from a patient with purulent meningitis using a
commercially available loop-mediated isothermal ampliﬁcation assay, resulting in a
prompt de-escalation of the initial empiric antibiotic therapy.
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Introduction
Neisseria meningitidis is the second most common cause of community-
acquired adult bacterial meningitis [1]. Invasive meningococcal disease (IMD) has
an overall mortality of 10% that can increase to 40% when septicemia occurs [2].
Waterhouse–Friderichsen syndrome is a severe complication of IMD, affecting
mainly young and previously well individuals [3]. It is characterized by clinical
adrenal insufﬁciency due to acute and massive hemorrhagic necrosis of the adrenal
glands as well as disseminated intravascular coagulation (DIC) [3]. In developed
countries, the use of serogroup C conjugate vaccines resulted in a signiﬁcant
decline of serogroup C-caused invasive diseases, and several years ago, a protein
*Corresponding author; E-mail: juergen.roedel@med.uni‑jena.de
Acta Microbiologica et Immunologica Hungarica 65 (3), pp. 309–315 (2018)
DOI: 10.1556/030.65.2018.021
First published online March 6, 2018
1217-8950/$20.00 © 2018 Akadémiai Kiado´, Budapest
vaccine against serogroup B meningococci has been introduced [4]. Fast micro-
biological diagnosis and immediate treatment are of vital importance for the
clinical outcome in patients with IMD [5]. The microbiological diagnosis of N.
meningitidis cerebrospinal ﬂuid (CSF) infection has several limitations. The
sensitivity of CSF Gram-staining ranges from 60% to 90% and accuracy depends
on the skills and experience of the operator [6]. Direct antigen detection assays
based on latex agglutination have a low sensitivity and speciﬁcity [5]. CSF culture
takes 1–2 days, but it can remain negative when antibiotic treatment has already
been started prior lumbar puncture [6]. Polymerase chain reaction (PCR) repre-
sents a sensitive and rapid method for identiﬁcation of bacteria in culture-negative
samples. However, multiplex PCR assays are often too laborious to be applied in
emergency diagnostics and fully automated rapid PCR tests are expensive [7].
Loop-mediated isothermal ampliﬁcation (LAMP) may serve as an alternative rapid
molecular technique that is easy to perform and does not require nucleic acid
puriﬁcation [8]. Recently, a Conformité Européenne-labeled IVD LAMP assay for
the detection of bacterial pathogens in CSF samples that cause relatively moderate
costs for consumables and equipment has been introduced (eazyplex® CSF direct,
Amplex Diagnostic, Gars Bahnhof, Germany). However, its usefulness under real
performance conditions needs to be evaluated.
Case Presentation
A 21-year-old female patient was hospitalized with massive cephalgia,
stiffness of the neck, fever, rapid disease progression, and a petechial rash
predominantly on the lower abdomen and legs, the latter having developed within
a few hours. High fever and chills had also occurred the day before admittance.
Several weeks ago, the patient had been treated with penicillin because of
tonsillitis. During clinical neurological examination, a native cerebral computer
tomography was conducted without clinical signs of cerebral edema. Axial
magnetic resonance images (MRI) depicted diffuse sulcal hyperintensities indi-
cating protein leakage due to the disturbance of the blood–brain barrier
(Figure 1A). MRI T1-weighted, contrast ﬂuid (gadolinium) imaging demonstrated
meningeal contrast enhancement (Figure 1B). CSF revealed a purulent appearance
with unexpectedly low pleocytosis of 837 cells/μl, a high protein content of 3.5 g/dl,
elevated lactate (6.2 mmol/L), and a glucose level of 3 mmol/L resulting in a low
glucose quotient of 38.5% (blood glucose level of 7.8 mmol/L). Serum laboratory
results showed elevated leukocytes (19.6 Gpt/L), C-reactive protein (221.7 mg/L),
procalcitonin (1.62 ng/ml), and bilirubin (32 μmol/L). Other laboratory ﬁndings
showed a mild DIC with a low thrombocyte count on day 2 (132 Gpt/L), decreased
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antithrombin III of 77%, and a decreased thromboplastin time (Quick) of 58%. Chest
X ray demonstrated a right-sided pleural effusion as well as an atelectasis of the right-
sided lower, middle, and partly upper lobe.
In the routine Pappenheim stain of the CSF sample, neutrophil granulocytes
were predominantly observed (>90%) (Figure 2A). In the Gram-stained prepara-
tion, Gram-negative diplococci with typical shape of meningococci could be
identiﬁed (Figure 2B). To rapidly verify microscopic results, an aliquot of the CSF
sample was tested using the eazyplex® CSF direct LAMP assay that targets the
most relevant meningitis-causing bacterial species (N. meningitidis, Streptococcus
pneumoniae, Haemophilus inﬂuenzae, Listeria monocytogenes, Streptococcus
agalactiae, and Escherichia coli). An amount of 125 μl of CSF was mixed with
25 μl of lysis solution and boiled for 3 min. Then, 125 μl of the lysed suspension
were mixed with 125 μl of resuspension solution buffer. An amount of 25 μl of the
suspension was added to each of the tubes of the eazyplex® test strip containing
the lyophilized master mixes for speciﬁc species and an inhibition control. The
strip was gently knocked to remove air bubbles and loaded into the Genie II
machine (Optigene Ltd., Horsham, UK; purchased from Amplex Biosystems).
The tests were carried out at 65 °C for 30 min. Ampliﬁcation was measured by
real-time ﬂuorescence detection using a DNA intercalating dye. Threshold times
Figure 1. Magnetic resonance imaging. (A) Fluid attenuated inversion recovery shows sulcal
hyperintensities, indicating protein leakage due to the disturbance of the blood–brain barrier. (B)
Slight intense meningeal contrast enhancement in coronal T1-weighted imaging after i.v. gadolinium
administration, demonstrating inﬂammation in this region
LAMP FOR IDENTIFICATION OF MENINGOCOCCI 311
Acta Microbiologica et Immunologica Hungarica 65, 2018
for ﬂuorescence intensity values and result interpretation were automatically
determined by the eazyplex® software. N. meningitidis was detected with a
threshold time of 9 min (Figure 2C). After reporting the result, initial empiric
combination treatment with ceftriaxone, ampicillin, and aciclovir was de-escalated
to ceftriaxone monotherapy. N. meningitidis serotype B was isolated from blood
culture (BACTEC Plus Aerobic/F, BD Diagnostics, Heidelberg, Germany) but not
from CSF samples inoculated onto Columbia sheep blood agar, chocolate agar
(Oxoid, Thermo Fisher Scientiﬁc, Wesel, Germany), and brain heart infusion (BD
Diagnostics). A blood culture bottle signaled bacterial growth at 18 h following its
arrival at the laboratory and species identiﬁcation was performed from subcultures
Figure 2. Microscopy and LAMP assay of the CSF sample. (A) Pappenheim stain demonstrates a
moderate cell number with predominant neutrophil granulocytes and few eosinophils and basophils
(original magniﬁcation 600×). (B) Gram stain shows granulocytes and Gram-negative diplococci
(original magniﬁcation 1,000×). (C) eazyplex® CSF direct ampliﬁcation curves with a positive
signal for N. meningitidis at a threshold time of 9 min (left curve). The inhibition control was positive
after 19 min (right curve)
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about 24 h later. Finetyping of the isolate was conducted according to protocols
described previously [9]. The strain had the molecular ﬁnetype B:P ( porA)1.7–
2.4:F ( fetA)1–5, which is the most prevalent type in Germany [10]. Sensitivity of
the isolate against ceftriaxone was conﬁrmed using Etest (minimum inhibitory
concentration: 0.004 mg/L), referred to the EUCAST breakpoint.
Follow-up blood cultures did not grow meningococci anymore. The patient
remained stable and vital signs were always in normal ranges. The decline of
thrombocytes on days 2 and 3 to a minimum of 132 Gpt/L improved without
intervention. Transcranial doppler ultrasonography revealed no brain vessel spasm
at different time points. Ceftriaxone was given at 4 g/day for 14 days and the
patient improved very fast, despite initial DIC with petechial rash. Breathing
training and balanced ﬂuid therapy attained a profound therapeutic effect on the
lung atelectasis. After mobilization and physiotherapy, patient could be dismissed
home on day 18 for further physical out-patient rehabilitation in fair clinical
condition.
Discussion
IMD belongs to the most serious infectious diseases. It can quickly become
life-threatening and surviving patients can develop long-term sequelae [2]. Rapid
initiation of appropriate antimicrobial therapy and intensive care is essential to
achieve the best outcome for the patient. In the classical workﬂow, N. meningitidis
infection is diagnosed by microscopy and culture [5]. However, culture is time-
consuming and often remains falsely negative when the patient has been pretreated
with antibiotics. Fast identiﬁcation of the bacterial species causing meningitis is
required to target the therapy and avoid an unnecessary broad antimicrobial
coverage as well as to decide whether prophylactic treatment of contact persons
has to be started [5, 6]. This case highlights the usefulness of LAMP for rapid
molecular diagnosis of bacterial meningitis. In comparison with PCR, a set of 4–6
primers is used for LAMP, and because of the high ampliﬁcation capacity under
isothermal conditions, the assays have a short running time [8, 11]. Moreover,
DNA puriﬁcation is not required, because the Bst DNA polymerase used for
LAMP tolerates PCR-inhibiting substances [8]. The eazyplex® CSF direct test
cannot differentiate N. meningitidis serotypes, but in a recent paper, the reliability
of a serotype-speciﬁc LAMP assay for identiﬁcation and typing of meningococci
has been demonstrated [11]. In this case report, the preliminary CSF Gram stain
result could immediately be veriﬁed using the eazyplex® CSF direct test, whereas
subsequent culture was negative, and bacteria were isolated only from blood
culture. Based on the eazyplex® result, the empirical treatment regime could be
LAMP FOR IDENTIFICATION OF MENINGOCOCCI 313
Acta Microbiologica et Immunologica Hungarica 65, 2018
adapted very soon. LAMP can be suggested as a diagnostic tool that facilitates the
diagnosis of bacterial meningitis and helps to overcome diagnostic challenges for
identifying N. meningitidis in CSF, in particular, in cases where the CSF Gram
stain result is uncertain or culture remains negative. Because of a low hands-on
time of less than 10 min, the eazyplex® CSF direct assay can easily be integrated
into a diagnostic routine workﬂow.
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